BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Phenomenex, Inc. Publishes Guide for Chiral Column Selection


3/15/2013 10:25:56 AM

Torrance, CA (March 14, 2013) - Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the publication of a guide to chiral column selection. Available in print and digital format, the 24-page guide is designed to help researchers quickly find the right column and method for their chiral compound, backed by a 45-day money-back guarantee on the recommended column. Over 250 applications are listed in the guide, indexed by functional groups. In addition to the new guide, researchers can find methods using the Phenomenex online Structure Search tool or by submitting their samples to the PhenoLogix chiral team, who will screen compounds at no charge, providing a method and column recommendation. Requests for the chiral column selection guide can be made online at: http://www.phenomenex.com/chiralguide.

"Chiral HPLC column selection is very challenging and typically involves a lot of trial and error," explained Michael Klein, chiral brand manager for Phenomenex. "Our new guide promises to help researchers pick the right column, the first time and every time, risk-free. Customers can use the guide, the online tools, or go straight to the free Chiral Screening Service, depending on the complexity of their challenge and their time constraints."

The Phenomenex chiral advantage is built around the company's polysaccharide-based Lux® media, which is available in five unique chiral stationary phases and has been demonstrated to resolve over 92 percent of enantiomers. Lux is available in particle sizes of 3-micron and 5-micron for packed columns (analytical, semi-preparative and Axia-packed preparative) as well as 10-micron and 20-micron bulk media for scale-up.

Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, clinical research, government and academic laboratories. From drug discovery and pharmaceutical development to food safety and environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being.

For more information on Phenomenex, visit www.phenomenex.com or follow the company on Twitter @Phenomenex.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES